Kinetics and In Vivo Distribution of In-111-Labelled Platelets and Platelet Function in Familial Hypercholesterolaemia

Summary

The kinetics, in vivo distribution and sites of sequestration of autologous In-111-labelled platelets and other platelet function parameters were studied in ten patients with type IIa or IIb familial hypercholesterolaemia and thrombotic complications of atherosclerosis. The in vitro platelet aggregation response to ADP (P = 0.50) and collagen (P = 0.46); binding of fibrinogen to platelets (P = 0.61); and plasma beta-thromboglobulin levels (P = 0.42) of the patients and normal reference subjects did not differ significantly. The in vivo distribution of In-111-labelled platelets at equilibrium was within normal limits, and at the end of platelet life-span the sequestration pattern of labelled platelets in the reticuloendothelial system was also normal (spleen P = 0.31; liver P = 0.54). There was minimal evidence of in vivo platelet activation: only mean platelet lifespan (MPLS), 195±57 hours (difference between mean MPLS of patients and controls was 25 hours, with a 95% confidence interval from 23 to 31 hours; P = 0.02); mean platelet platelet turnover, 2298±824 platelets/μl/hour (P = 0.005); plasma platelet factor 4 (P = 0.02); and the mean circulating platelet aggregate ratio, 0.8±0.1 (P = 0.02); differed significantly from normal. These results suggest that abnormalities of platelet function and kinetics observed in type II hyperlipoproteinaemia cannot be ascribed wholly to the hyperlipidaemia, but may be induced by the associated atherosclerosis.

Keywords

Hypercholesterolaemia - In-111-labelled platelets - Platelet function - Platelet kinetics - Platelet lifespan

• References

• 1 Wyndham CH. The loss from premature deaths of economically active manpower in the various populations of the R.S.A. Part I, Leading causes of death: health strategies for reducing mortality. S Afr Med J 1981; 60: 411-419
• 2 Seftel HC, Baker SG, Sandler MP, Forman MB, Joff BI, Mendelsohn D, Jenkins T, Mieny CJ. A host of hypercholes- terolaemic homozygotes in South Africa. Br Med J 1980; 281: 633-636
• 3 Ross R, Harker LA. Hyperlipidemia and atherosclerosis: chronic hyperlipidemia initiates and maintains lesions by endothelial cell desquamation and lipid accumulation. Science 1976; 193: 1094-1100
• 4 Fischer-Dzoga K, Fraser RA, Wissler RW. Stimulation of proliferation in stationary primary cultures of monkey and rabbit aortic smooth muscle cells. I. Effects of lipoprotein fractions of hyperlipidemic serum and lymph. Exp Mol Pathol 1976; 24: 246-359
• 5 Ross R. The pathogenesis of atherosclerosis - An update. N Engl J Med 1986; 314 (08) 488-500
• 6 Beaumont JL, Carlson LA, Cooper GR, Frederickson DS, Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull WHO 1970; 43: 891-908
• 7 Heyns A duP, Lotter MG, Badenhorst PN, Van Reenen OR, Pieters H, Minnaar PC, Retief FP. Kinetics, distribution and sites of destruction of Indium-111-labelled human platelets. Br J Haematol 1980; 44: 269-280
• 8 Heyns A duP, Lotter MG, Badenhorst PN. Platelet Imaging. In: Methods in Haematology. Harker LA, Zimmerman TS. (eds.). Churchill Livingstone; New York: 1983. pp. 216-234
• 9 Wessels P, Heyns A duP, Pieters H, Lotter MG, Badenhorst PN. An improved method for the quantification of the in vivo kinetics of a representative population of In-111-labelled human platelets. Eur J Nucl Med 1985; 10: 522-527
• 10 Heyns A duP, Badenhorst PN, Pieters H, Lotter MG, Minnaar PC, Duyvene de Wit LJ, Van Reenen OR, Retief FP. Preparation of a viable population of Indium-111-labelled human blood platelets. Thromb Haemostas 1980; 42: 1473-1482
• 11 Murphy EA, Francis ME. The estimation of blood platelet survival II. The multiple hit model. Thromb Diath Haemorrhag 1971; 25: 53-80
• 12 Kotze HF, Lotter MG, Badenhorst PN, Heyns A duP. Kinetics of In-111-platelets in the baboon: II. In vivo distribution and sites of sequestration. Thromb Haemostas 1985; 53: 408-410
• 13 Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969; 48: 963-974
• 14 Sirridge MS, Shannon R. Laboratory evaluation of hemostasis and thrombosis. Lea … Febiger; Philadelphia: 1983. pp. 86-99
• 15 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet. 1974; II: 924-926
• 16 Plow EF, Byers V, Marquerie GA. The interaction of fibrinogen with its platelet receptor: A methodological approach for receptor identification and characterization. In: Measurements of platelet function. Harker LA, Zimmerman TS. (eds.) Churchill Livingstone; New York: 1983. pp. 177-188
• 17 Gardner MJ, Douglas GA. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 1986; 292: 746-750
• 18 Harker LA, Hazzard W. Platelet kinetics studies in patients with severe hyperlipoproteinaemia: Effect of clofibrate therapy. Circulation 1979; 60: 492-496
• 19 Corash L, Andersen J, Poindexter BJ, Schaefer EJ. Platelet function and survival in patients with severe hypercholesterolemia. Arteriosclerosis 1981; 1: 443-448
• 20 Molinas FC, Drucker E, Kordich L, Reynolds MA, Finkielman S. Platelet function and antithrombins in hyperlipoproteinemia type II a. Thromb Res 1981; 22: 427-435
• 21 Zucker ML, Trowbridge C, Krehbiel P, Jackson B, Chernoff SB, Dujovne CA. Platelet function in hypercholesterolaemics before and after hypolipidemic drug therapy. Haemostasis 1986; 16: 57-64
• 22 Carvalho A CA, Colman RW, Lees RS. Platelet function in hyperhpoproteinemia. N Engl J Med 1974; 290: 434-438
• 23 Shattil SJ, Bennett JS, Colman RW, Cooper RA. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia. J Lab Clin Med 1977; 89: 341-353
• 24 Shaslri KM, Carvalho A CA, Lees RS. Platelet function and platelet lipid composition in the dyslipoprotciuacniias. J Lipid Res 1980; 21: 467-472
• 25 Aviram M, Brook TG. The effect of human plasma on platelet function in familial hypercholesterolemia. Thromb Res 1982; 26: 101-109
• 26 Trcmoli E, Madcrna P, Colli S, Morazzoni G, Sirtori M, Sirtori E. Increased platelet sensitivity and thromboxane B2 formation in type-II hyperlipoproteinaemic patients. Eur J Clin Invest 1984; 14: 329-333
• 27 Renaud S, Kinlough RL, Mustard JF. Relationship between platelet aggregation and the thrombotic tendency in rats fed hyperlipidaemic diets. Lab Invest 1970; 22: 339-343
• 28 Joist JH, Dolezel G, Kinlough-Rathbone RL, Mustard JF. Effect of diet-induced hyperlipidemia on in vitro-function of rabbit platelets. Thromb Res 1976; 9: 435-445
• 29 Packham MA, Kinlough-Rathbone RL, Reimers HJ, Scott S, Mustard JF. Mechanisms of platelet aggregation independent of adenosine diphosphate. In: Prostaglandins in Hematology. Silver MJ. et al (eds). Spectrum; New York: 1977. pp. 247-276
• 30 Kaplan KL, Owen J. Plasma levels of B-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
• 31 Dawes J, Smith RC, Pepper DS. The release, distribution and clearance of human B-thromboglobulin and platelet factor 4. Thromb Res 1978; 12: 851-861
• 32 Nordoy A, Brox JH, Holme S, Killie JE, Lenner RA. Platelets and coagulation in patients with familial hypercholesterolemia (type IIa). Acta Med Scand 1983; 213: 129-135
• 33 Zahavi J, Betteridge JD, Jones N AG, Galton DJ, Kakkar VV. Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia. Am J Med 1981; 70: 59-64
• 34 Steele MD. Platelet reactivity and hyperlipidemia. In: Platelets and prostaglandins in cardiovascular disease. Mehta J, Mehta P. (eds.). Futura Publishing Co.; Mount Kisco, NY: 1981. pp. 295-299
• 35 Joist JH, Baker RK, Schonfeld G. Increased in vivo and in vitro platelet function in type I and type IV hyperlipoproteinaemia. Thromb Res 1979; 15: 95-108
• 36 Sano T, Motomiya T, Ymazaki H. Influence of lipid metabolism on platelet activation in vivo. Thromb Res 1983; 31: 675-684
• 37 Wu KK, Armstrong ML, Hoak JC, Megan MB. Platelet aggregates in hypercholesterolaemic rhesus monkeys. Thromb Res 1975; 7: 917-925
• 38 Steele P, Rainwatei K. Effect of dietaiy and pharmacologic alteration of scrum lipids on platelet survival time. Circulation 1978; 58: 365-367
• 39 Armstrong ML, Peterson RE, Hoak JC, Megan MB, Cheng FH, Clarke WR. Arterial platelet accumulation in experimental hyper- cholcstcrolacmia. Atherosclerosis 1980; 36: 89-100
• 40 Barrett PA, Butler KD. Shortening of platelet survival by induced hypercholesterolaemia in rabbits and its prolongation by anagrelidc. Thromb Haemostas 1983; 50: 656-659
• 41 Wanless IR. The effect uf dietary cliolesteiul on platelet suivival in the rabbit - a study using C-14-serotonin and chromium-51-double labelled platelets. Thromb Haemostas 1984; 52: 85-89
• 42 Kinlough-Rathbone RL, Packham MA, Mustard JF. Vessel injury, platelet adherence, and platelet survival. Arterioselerosis 1983; 3: 529-546
• 43 Shatill SJ, Cooper RA. Role of membrane lipid composition, organization, and fluidity in human platelet function. Prog Haemost Thromb 1978; 4: 59-86
• 44 Heyns A duP, Lotter MG, Kotze HF, Pieters H, Herbst C, Nel C JC, Minnaar PC. Kinetics and fate of Indium 111-oxine labeled platelets in patients with aortic aneurysms. Arch Surg 1982; 177: 1170-1174